Video

Dr Oliver Dorigo Discusses an Interdisciplinary Approach to Care in Gynecologic Oncology

An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.

An interdisciplinary approach to patient care is very important because the treatment of gynecologic cancers can be very complex, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.

Transcript

How does your division at Stanford utilize an interdisciplinary approach to patient care?

An interdisciplinary approach to patient care, in my opinion, is very important since the treatment of gynecologic cancers can be very complex. Our patients are seen initially in our clinic, but upon diagnosis, they are then treated by an interdisciplinary team that does include the gynecologic oncologist, the radiation oncologist, radiologist, pathologist, and the palliative care service.

We nowadays believe that palliative care is a very important aspect of gynecologic cancer care from the very first beginning since we want to help patients with the diagnosis, the psychological aspect of having been diagnosed with cancer, and also side effects that are related to the treatment.

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Screenshot of Susan Wescott, RPh, MBA
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Interview screenshot with Megan Ehret, PharmD
Screenshot of an interview with Susan Wescott, RPh, MBA
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo